American Conference Institute (ACI) will be holding its 14th Annual Paragraph IV Disputes master symposium on April 27-28, 2020 in New York City.
The conference will offer presentations on the following topics:
• Strategic Legal and Economic Guidance in View of Regulatory and Jurisprudential Developments
• Assessing the Limitations and Prospects of Obviousness-Type Double Patenting
• The Continuing §101 Saga: Seeking Clarity from the PTO and the Courts on Subject Matter Eligibility
• The Doctrine of Equivalents: Analyzing the Effects of Recent Federal Circuit Decisions on Litigation Strategies
• A Matter of Constitutionality: The PTAB Appointment Clause and the Increased Responsibility of AIA Trials
• PTAB APJs discuss practice, policy, and procedure
• Comparing and Contrasting the Similarities and Differences Driving Efficiencies in Hatch-Waxman and BPCIA Litigation
• FDA Think Tank on the Latest Regulatory Developments Impacting Hatch-Waxman
• Ethics and New Developments impacting Professional Responsibility in the Hatch-Waxman Arena
The conference will offer "A View from the Federal Circuit" from Hon. Kathleen M. O'Malley, Federal Circuit judge, interviewed by Hon. Mary Pat Thynge, Chief Magistrate Judge from the District of Delaware. Marcus H. Meier from the FTC will discuss antitrust developments in disputes between brand and generic drug makers. And there will be a "Morning Roll Call" with district court judges from some of the liveliest PIV jurisdictions.
Concurrent advanced tracks will be offered on "Understanding and Harnessing the Nuances of Local Rules"; "Effectively Managing Global Patent Litigation"; "Evaluating the Effectiveness of Summary Judgment in Different Venues"; "Practical Strategies and Tactics for Effective Settlement Negotiation"; Appreciating the Magistrate Judge's Role in Settlement Discussions"; "Devising Strategies for Proving Infringement and Defending Validity"; "Advanced Pleadings Drafting: Choosing Claims and Defenses Wisely"; "Selecting and Effectively Using Expert Witnesses in Pharmaceutical Patent Litigation"; and "Diversity and Inclusion, Incorporation and Implementation: A Guide for Creating a Successfuk IOP Team." There will be a Town Hall presentation from a panel of magistrate judges, and presentations on "New Developments in Market Access and Exclusivities."
In addition, two post-conference workshops will be offered on April 29, 2020. The first, entitled "Think Tank on State and Federal Pharmaceutical IP Antitrust Initiatives: Patent Settlements, Reverse Payments, and Emerging Legislation" will be offered from 8:30 am to 11:30 am, and the second, entitled "Working Group on IPR Strategies and Parallel Proceedings: Devising Winning Strategies for IPR Best Practices and Navigating Dual Forums in Hatch-Waxman Litigation" will be offered from 12:30 to 4:00 pm.
A complete brochure for this conference, including an agenda, detailed descriptions of conference sessions, list of speakers, and registration form can be obtained here.
The registration fee is $2,295 (conference alone) or $3,295 (conference and both workshops) for registration before March 8, 2020. The workshops are $600 apiece, and there is a special in-house All Access Pass for $2,795. Patent Docs readers are entitled to a 10% discount off of registration using discount code D10-896-896CX03. Those interested in registering for the conference can do so here, by e-mailing [email protected], or by calling 1-888-224-2480.
Patent Docs is a media partner of ACI's Paragraph IV Disputes Master Symposium.
Comments